Identification of a novel cardiac epitope triggering T-cell responses in patients with myocardial infarction

J Mol Cell Cardiol. 2022 Dec:173:25-29. doi: 10.1016/j.yjmcc.2022.09.001. Epub 2022 Sep 16.

Abstract

T-cells contribute to pathophysiological processes in myocardial diseases, including myocardial infarction (MI) and heart failure (HF). Antigen-specificity is a hallmark of T-cell responses but the cardiac antigens that trigger heart-directed T-cell responses in patients have not yet been uncovered, thus posing a roadblock to translation. In the present exploratory study, we identified a peptide fragment of the beta-1 adrenergic receptor (ADRB1) that elicits CD4+ T-cell responses after myocardial infarction in patients with a defined HLA haplotype. Our observations may advance the development of tools to monitor other antigen-specific immune responses in patients.

Keywords: Adrenergic receptor beta-1; Cardiac antigens; HLA-DRB1*13; Myocardial infarction; T-cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • CD4-Positive T-Lymphocytes*
  • Epitopes
  • Heart
  • Humans
  • Myocardial Infarction*

Substances

  • Epitopes